Two Paths to Ketamine Treatment
If you are considering ketamine therapy for depression, one of the first decisions you will face is whether to pursue treatment in a clinical setting or through an at-home program. Both approaches use the same active medication, but they differ significantly in cost, convenience, dosing, and level of supervision.
Neither option is universally better -- the right choice depends on your specific clinical situation, budget, and preferences. This guide breaks down the key differences to help you make an informed decision.
Head-to-Head Comparison
| Factor | Clinic (IV/Spravato) | At-Home (Oral/Sublingual) |
|---|---|---|
| Cost per month | $1,600-$3,200+ (initial phase) | $124-$350/month |
| Initial series cost | $2,400-$4,800 (6 infusions) | $124-$350 (first month) |
| Consultation fee | $150-$350 | $0-$250 (Kalm: $0) |
| Administration | IV drip or nasal spray in office | Sublingual tablets at home |
| Time commitment | 2-3 hours per session + travel | 30-60 minutes at home |
| Frequency | 2-3x/week initially, then monthly | Daily or several times/week |
| Supervision | In-person medical staff present | Telehealth check-ins; sitter recommended |
| Bioavailability | ~100% (IV), ~48% (nasal) | ~25-30% (sublingual) |
| Dose flexibility | Varies by clinic | Varies by provider (Kalm: no cap) |
| Insurance coverage | Spravato sometimes covered | Generally not covered |
The Cost Reality
Cost is often the deciding factor for depression patients, and the difference between clinic and at-home treatment is dramatic:
Clinic IV Infusions
A standard initial protocol involves 6 infusions over 2-3 weeks, typically costing $400-$800 per session. That is $2,400-$4,800 for the introductory series alone. Maintenance infusions (usually monthly) continue at the same per-session rate. Annual cost: $7,200-$14,400+ including the initial series.
At-Home Sublingual Therapy
At-home providers charge a monthly subscription that includes the medication, prescriber oversight, and telehealth support. With Kalm Health at $124/month, annual cost is approximately $1,488. Even at the higher end of at-home providers ($300-$350/month), the annual cost is $3,600-$4,200 -- still less than a single initial IV series.
A depression patient choosing at-home treatment with Kalm Health at $124/month would spend approximately $1,488 per year. The same patient pursuing IV clinic infusions could spend $7,200-$14,400+ annually -- a difference of 5-10x. For many treatment-resistant depression patients who need long-term maintenance therapy, this cost difference determines whether treatment is sustainable.
Convenience and Accessibility
For patients already struggling with depression, logistical barriers can be significant obstacles to consistent treatment:
- Clinic visits require travel, parking, spending 2-3 hours in a medical facility, arranging transportation home (you cannot drive after IV ketamine), and fitting appointments into work schedules
- At-home treatment can be done in the evening or on your own schedule, requires no travel, and involves no time away from work or family obligations
- Geographic access: IV ketamine clinics are concentrated in major metropolitan areas. At-home telehealth programs serve most U.S. states regardless of proximity to a clinic
For patients with severe depression, the energy required to leave the house, drive to a clinic, and sit in a medical office can itself be a significant barrier. At-home treatment removes that obstacle entirely.
Dosing and Effectiveness
One common concern about at-home therapy is whether lower-bioavailability oral or sublingual ketamine is as effective as IV infusions. Here is what the evidence suggests:
- IV ketamine has the highest bioavailability (~100%) and produces the most intense acute experience per dose
- Sublingual ketamine (bioavailability ~25-30%) is dosed accordingly to achieve therapeutic blood levels
- Regular, sustained dosing with oral/sublingual ketamine may provide more consistent antidepressant effects than periodic IV infusions with gaps between sessions
- Some researchers argue that the neuroplasticity benefits of ketamine are best maintained through frequent, regular dosing rather than intermittent high-dose sessions
The critical factor is dose flexibility. Some at-home providers impose arbitrary dose caps that can limit your clinician's ability to optimize treatment. This is especially problematic for treatment-resistant depression patients who may need higher doses. Kalm Health stands out by having no dose cap, allowing prescribers to adjust based on clinical response. Learn more about dosing at Ketamine Dose Guide.
Who Should Choose Clinic Treatment?
Clinic-based ketamine therapy may be more appropriate if you:
- Have severe medical comorbidities requiring in-person monitoring
- Prefer the reassurance of on-site medical staff during treatment
- Have not responded to oral/sublingual ketamine and want to try IV administration
- Have insurance that covers Spravato (esketamine) treatment
- Are in acute crisis and need the fastest possible intervention
Who Should Choose At-Home Treatment?
At-home ketamine therapy is typically the better fit if you:
- Need an affordable long-term treatment option
- Value convenience and prefer treating at home on your schedule
- Do not live near a ketamine clinic
- Want sustained, regular dosing rather than periodic infusions
- Are comfortable with telehealth-based medical supervision
- Need dose flexibility for treatment-resistant depression
Our Recommendation for Depression Patients
For the majority of depression patients exploring ketamine therapy, at-home treatment offers the best combination of affordability, accessibility, and clinical flexibility. Among at-home providers, Kalm Health provides the strongest value proposition:
Kalm Health
- $124/month -- lowest ongoing cost in the market
- $0 consultation -- no financial risk to get evaluated
- No dose cap -- your clinician can optimize freely
- Higher-dose plan: $174 every two months for patients needing more
Compare all at-home and clinic providers in our full provider guide, or learn about insurance and cost strategies.